The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
A | Alimentary tract and metabolism | |
2
|
A10 | Drugs used in diabetes | |
3
|
A10B | Blood glucose lowering drugs, excl. insulins | |
4
|
A10BF | Alpha glucosidase inhibitors |
| Code | Title | |
|---|---|---|
| A10BF01 | Acarbose | |
| A10BF02 | Miglitol | |
| A10BF03 | Voglibose |
| Active Ingredient |
|---|
|
Acarbose is an alpha-glucosidase inhibitors, used in the treatment of diabetes. Inhibitors of a-glucosidase retard the breakdown of carbohydrates in the food and reduce the increase in blood glucose levels, which occurs after each meal. |
|
Miglitol is a reversible inhibitor of intestinal alpha-glucosidases. Under the influence of miglitol, the digestion of complex carbohydrates into absorbable monosaccharides in the small intestine is dosedependently delayed. Administration of miglitol thus leads to reduced postprandial hyperglycaemia and a smoothing effect on fluctuations in the daily blood glucose profile. |
|
|
| Document | Type | Information Source | |
|---|---|---|---|
| GLUCOBAY 50mg Tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |